MedicaidCoverageLow impact
Newsletter Vol. 9, No. 66
New Jersey Medicaid·NJ·Pharmacy
Effective date
Mar 9, 1999
We identified it
Jun 20, 2026
Summary
New Jersey has added two pharmaceutical manufacturers (Zila Pharmaceuticals and Faulding Pharmaceutical Company) to the PAAD Drug Rebate Program. These additions were effective in March 1999 and allow eligible aged and disabled patients to access medications from these manufacturers through the state assistance program.
Action Required
No immediate action required for billing teams outside New Jersey. New Jersey providers should retain this newsletter in their policy documentation and be aware that medications from Zila Pharmaceuticals (labeler code 51284) and Faulding Pharmaceutical Company (labeler code 61703) are now covered under the PAAD program for eligible patients.